rs1805199

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000834.5(GRIN2B):​c.1126-73A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.816 in 1,189,670 control chromosomes in the GnomAD database, including 398,972 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.76 ( 45053 hom., cov: 33)
Exomes 𝑓: 0.82 ( 353919 hom. )

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.704

Publications

8 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-13616730-T-C is Benign according to our data. Variant chr12-13616730-T-C is described in ClinVar as Benign. ClinVar VariationId is 1290979.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.968 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
NM_000834.5
MANE Select
c.1126-73A>G
intron
N/ANP_000825.2Q13224
GRIN2B
NM_001413992.1
c.1126-73A>G
intron
N/ANP_001400921.1A0A8D9PHB2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
ENST00000609686.4
TSL:1 MANE Select
c.1126-73A>G
intron
N/AENSP00000477455.1Q13224
GRIN2B
ENST00000630791.3
TSL:5
c.1126-73A>G
intron
N/AENSP00000486677.3A0A0D9SFK0
ENSG00000287928
ENST00000652867.1
n.331+1504T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.760
AC:
115608
AN:
152066
Hom.:
45033
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.581
Gnomad AMI
AF:
0.855
Gnomad AMR
AF:
0.828
Gnomad ASJ
AF:
0.745
Gnomad EAS
AF:
0.991
Gnomad SAS
AF:
0.855
Gnomad FIN
AF:
0.863
Gnomad MID
AF:
0.848
Gnomad NFE
AF:
0.813
Gnomad OTH
AF:
0.766
GnomAD4 exome
AF:
0.824
AC:
854632
AN:
1037486
Hom.:
353919
AF XY:
0.825
AC XY:
441148
AN XY:
534928
show subpopulations
African (AFR)
AF:
0.580
AC:
14659
AN:
25276
American (AMR)
AF:
0.894
AC:
39409
AN:
44090
Ashkenazi Jewish (ASJ)
AF:
0.745
AC:
17498
AN:
23500
East Asian (EAS)
AF:
0.990
AC:
37464
AN:
37830
South Asian (SAS)
AF:
0.851
AC:
66010
AN:
77550
European-Finnish (FIN)
AF:
0.864
AC:
44927
AN:
52000
Middle Eastern (MID)
AF:
0.791
AC:
3904
AN:
4936
European-Non Finnish (NFE)
AF:
0.817
AC:
592815
AN:
725870
Other (OTH)
AF:
0.817
AC:
37946
AN:
46434
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
8193
16387
24580
32774
40967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11010
22020
33030
44040
55050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.760
AC:
115675
AN:
152184
Hom.:
45053
Cov.:
33
AF XY:
0.767
AC XY:
57072
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.581
AC:
24097
AN:
41488
American (AMR)
AF:
0.828
AC:
12660
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.745
AC:
2585
AN:
3472
East Asian (EAS)
AF:
0.991
AC:
5135
AN:
5182
South Asian (SAS)
AF:
0.855
AC:
4123
AN:
4822
European-Finnish (FIN)
AF:
0.863
AC:
9148
AN:
10598
Middle Eastern (MID)
AF:
0.844
AC:
248
AN:
294
European-Non Finnish (NFE)
AF:
0.813
AC:
55272
AN:
68012
Other (OTH)
AF:
0.770
AC:
1629
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1325
2650
3975
5300
6625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.796
Hom.:
79488
Bravo
AF:
0.752
Asia WGS
AF:
0.910
AC:
3158
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.54
DANN
Benign
0.58
PhyloP100
-0.70
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1805199; hg19: chr12-13769664; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.